1,200.00p-30.00 (-2.44%)06 Nov 2025, 17:07
Jump to:
Cvs Group PLC Fundamentals
| Company Name | Cvs Group PLC | Last Updated | 2025-11-06 |
|---|---|---|---|
| Industry | Medical Care Facilities | Sector | Healthcare |
| Shares in Issue | 71.504 m | Market Cap | £858.04 m |
| PE Ratio | 46.95 | Dividend per Share | £0.08 |
| Dividend Yield | 0.65 | Dividend Cover | 3.28 |
| EPS | £0.74 | EPS Growth (%) | -0.23 |
| PEG | 0 | DPS Growth (%) | 0.0667 |
| Debt Ratio | 0.3574 | Debt Equity Ratio | 0.7792 |
| Asset Equity Ratio | 2.3076 | Cash Equity Ratio | 0.0534 |
| Quick Ratio | 0.5848 | Current Ratio | 1.10 |
| Price To Book Value | 2.8612 | ROCE | 0 |
Cvs Group PLC Dividends
| Type | Ex-Date | Pay Date | Currency | Net Dividend | Year Total |
|---|---|---|---|---|---|
| Prelim | 2025-11-06 | 2025-12-05 | GBP | 0.0850 | |
| Prelim | 2024-10-31 | 2024-11-29 | GBP | 0.0800 | |
| Prelim | 2023-11-02 | 2023-12-08 | GBP | 0.0750 | |
| Prelim | 2022-11-17 | 2022-12-02 | GBP | 0.0700 |
Cvs Group PLC Company Financials
| Assets | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Tangible Assets | £222.40 m | £225.60 m | £204.40 m | £171.40 m |
| Intangible Assets | £337.60 m | £334.90 m | £256.10 m | £216.50 m |
| Investments | 0 | 0 | 0 | £100,000.00 |
| Total Fixed Assets | £560.80 m | £561.40 m | £460.50 m | £390.30 m |
| Stocks | £28.50 m | £31.80 m | £28.40 m | £26.20 m |
| Debtors | £56.00 m | £55.50 m | £47.10 m | £42.10 m |
| Cash & Equivalents | £16.10 m | £16.50 m | £21.50 m | £49.00 m |
| Other Assets | £800,000.00 | £900,000.00 | 0 | £2.30 m |
| Total Assets | £696.20 m | £690.00 m | £572.30 m | £518.20 m |
| Liabilities | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Creditors within 1 year | £123.30 m | £118.10 m | £105.10 m | £101.40 m |
| Creditors after 1 year | £271.20 m | £311.40 m | £210.20 m | £199.40 m |
| Other Liabilities | 0 | 0 | 0 | 0 |
| Total Liabilities | £394.50 m | £429.50 m | £315.30 m | £300.80 m |
| Net assets | £301.70 m | £260.50 m | £257.00 m | £217.40 m |
| Equity | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Called up share capital | £100,000.00 | £100,000.00 | £100,000.00 | £100,000.00 |
| Share Premium | £109.70 m | £109.60 m | £107.60 m | £106.00 m |
| Profit / Loss | £32.60 m | £35.20 m | £60.70 m | £36.00 m |
| Other Equity | £299.80 m | £260.40 m | £257.00 m | £217.40 m |
| Preference & Minorities | £1.90 m | £100,000.00 | 0 | 0 |
| Total Capital Employed | £301.70 m | £260.50 m | £256.60 m | £217.40 m |
| Ratios | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Debt Ratio | £0.44 | £0.51 | £0.42 | £0.45 |
| Debt-to-Equity | £0.78 | £1.05 | £0.72 | £0.83 |
| Assets / Equity | 2.3076 | 2.3076 | 2.3076 | 2.3076 |
| Cash / Equity | 0.0534 | 0.0534 | 0.0534 | 0.0534 |
| EPS | £0.26 | £0.34 | £0.68 | £0.36 |
| Cash Flow | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Cash from operating activities | £82.10 m | £67.80 m | £84.50 m | £75.50 m |
| Cashflow before financing | £22.90 m | £136.10 m | £72.40 m | £60.40 m |
| Increase in Cash | -£400,000.00 | -£5.00 m | -£27.50 m | £15.30 m |
| Income | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Turnover | £673.20 m | £638.70 m | £588.90 m | £554.20 m |
| Cost of sales | £387.50 m | £370.00 m | £330.80 m | £315.10 m |
| Gross Profit | £285.70 m | £268.70 m | £258.10 m | £239.10 m |
| Operating Profit | £49.80 m | £47.80 m | £68.40 m | £42.80 m |
| Pre-Tax profit | £32.60 m | £35.20 m | £60.70 m | £36.00 m |
Cvs Group PLC Company Background
| Sector | Healthcare |
|---|---|
| Activities | CVS Group PLC is a veterinary service provider in the United Kingdom. The group operates through three business divisions: Veterinary Practices, Laboratories, Crematoria, and Online Retail Business. The veterinary practice segment generates the majority of the revenues. The company facilitates its veterinary services through its diagnostics, laboratory reports, and pet cremation services. It also offers retail pharmacy through Animed Direct. Geographically, it generates themajority of its revenue from the United Kingdom and also operates in Australia. |
| Latest Interim Date | 27 Feb 2025 |
| Latest Fiscal Year End Date | 7 Oct 2025 |
Cvs Group PLC Directors
| Appointed | Name | Position |
|---|---|---|
| 2025-10-07 | Mr. Richard Andrew Gray | Non-Executive Director |
| 2024-09-28 | Mr. Simon Campbell Innes | Executive Director,Chief Executive |
| 2013-04-02 | Mr. David Peter Timmins | Non-Executive Director |
| 2010-06-30 | Mr. Christopher Alan Marsh | Non-Executive Director |
| 2023-10-27 | Mr. Richard Andrew Connell | Non-Executive Director,Chairman |
| 2021-09-23 | Mr. Michael Kinloch McCollum | Non-Executive Director |
| 2025-10-07 | Mr. David Charles Wilton | Non-Executive Director,Chairman |
| 2013-09-26 | Mr. Paul Daryl Coxon | Executive Director,Finance Director and Company Secretary |
| 2011-08-09 | Mr. Mark Finn | Executive Director,Operations Director |
| 2025-10-07 | Ms. Deborah Jane Kemp | Non-Executive Director,Senior Independent Director |
| 2021-09-23 | Mr. Nicholas John Perrin | Executive Director,Group Finance Director |
| 2025-08-01 | Mr. Richard William Mark Fairman | Executive Director,Chief Executive Officer |
| 2024-06-18 | Mr. Benjamin David Jacklin | Executive Director,Deputy Chief Executive Officer |
| 2025-10-07 | Mr. Robin Jay Alfonso FCA | Executive Director,Finance Director |
| 2025-01-07 | Ms. Joanne Mary Shaw | Non-Executive Director |
| 2025-09-15 | Mr. Paul Stephen Higgs | Executive Director,Chief Veterinary Officer |
Cvs Group PLC Contact Details
| Company Name | CVS Group PLC |
|---|---|
| Address | Owen Road, CVS House, Diss, IP22 4ER |
| Telephone | +44 1379644288 |
| Website | https://www.cvsukltd.co.uk |
Cvs Group PLC Advisors
| Auditor | Deloitte LLP |
|---|---|
| Phone | +44 1223460222 |
| Fax | +44 1223350839 |
| Remuneration Consultant | h2glenfern Limited |
|---|---|
| Phone | +44 2071600570 |
| Bank | HSBC Bank PLC |
|---|
| Registrar | Neville Registrars Ltd |
|---|---|
| Phone | +44 1215851131 |
| Fax | +44 1215851132 |
| Solicitor | Leathes Prior |
|---|---|
| Phone | +44 1603610911 |
| Fax | +44 1603610088 |
| Bank | National Westminster Bank PLC |
|---|
| Bank | Royal Bank of Scotland PLC |
|---|
| Stockbroker | N+1 Singer |
|---|---|
| Phone | +44 2074963000 |
| Fax | +44 2074963150 |
| Nominated Adviser | N+1 Singer |
|---|---|
| Phone | +44 2074963000 |
| Fax | +44 2074963150 |
Most Read
Receive our
daily news email
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine

Plus more useful investment content and occasional promotional offers.
Market Overview
UK 350 Risers and Fallers
Risers
| Company | Price | % Chg |
|---|---|---|
| Helios Towers PLC | 171.80 | 10.84 |
| Rs Group PLC | 595.00 | 7.69 |
| Sainsbury (J) PLC | 355.80 | 5.52 |
| Osb Group PLC | 552.50 | 5.04 |
| Hochschild Mining PLC | 336.40 | 4.93 |
| Energean PLC | 1,023.00 | 3.75 |
Fallers
| Company | Price | % Chg |
|---|---|---|
| Hikma Pharmaceuticals PLC | 1,522.00 | -14.06 |
| Tbc Bank Group PLC | 3,785.00 | -11.87 |
| Smith & Nephew PLC | 1,242.00 | -10.87 |
| Goodwin PLC | 21,200.00 | -9.01 |
| Ashmore Group PLC | 170.80 | -8.86 |
| Diageo PLC | 1,680.00 | -6.54 |
Risers/fallers data from previous trading day. Today's data available from 8:15am.